Table 2 Basic characteristics of lPCa and cPCa patients
Characteristics median (IQR)/ (%) | lPCa | cPCa |
|---|---|---|
Prostate volume | 29.4 (27.5–40.2) | 34.5 (27.8–44.7) |
Total tumor volume/ml | 0.055 (0.007–0.304) | 2.128 (0.822–4.566) |
Index tumor volume/ml | 0.032 (0.004–0.138) | 1.545 (0.466–4.045) |
Tumor volume group | ||
Volume ≥ 0.5 ml | 3 (12.5) | 104 (82.5) |
Volume < 0.5 ml | 21 (87.5) | 22 (17.5) |
ISUP classification | ||
1 | 11 (45.8) | 10 (7.9) |
2 | 8 (33.3) | 59 (46.8) |
3 | 0 (0.0) | 33 (26.2) |
4 | 1 (4.2) | 10 (7.9) |
5 | 4 (16.7) | 14 (11.1) |
EPE | 4 (16.7) | 46 (36.3) |
csPCa | 13 (54.2) | 119 (94.4) |
Spatial distribution of tumors | ||
Anterior zone | 12 (50.0) | 63 (50.0) |
Posterior zone | 10 (41.7) | 50 (39.7) |
Both anterior and posterior zone | 2 (8.3) | 13 (10.3) |
Peripheral zone | 19 (79.2) | 82 (65.1) |
Transitional zone | 4 (16.7) | 15 (11.9) |
Both peripheral and transitional zone | 1 (4.2) | 29 (23.0) |
Apical 1/3 region | 12 (50.0) | 111 (88.1) |
Middle 1/3 region | 16 (66.7) | 111 (88.1) |
Basal 1/3 region | 3 (12.5) | 50 (39.6) |